|4Sep 24, 5:02 PM ET

Chilcott, III Thomas E. 4

4 · Ampio Pharmaceuticals, Inc. · Filed Sep 24, 2018

Insider Transaction Report

Form 4
Period: 2018-09-20
Chilcott, III Thomas E.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-09-20+75,00075,000 total
    Exercise: $0.51Exp: 2028-09-20Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]The stock option has vested and has become fully exercisable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION